888P - Preclinical and Early Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Exportin 1 (Xpo1) Antagonist Selinexor (Kpt-330) in Patients (Pts) with Platinum Resistant/Refractory Ovarian Cancer (Ovca)
| Autor: | Martignetti, J., Razak, A.R.A., Chen, Y., Gabrail, N.Y., Gericitano, J.F., Camacho, C., Pereira, E., Evans, B., Dottino, P., McCauley, D., Shacham, S., Rashal, T., Saint-Martin, J., Shacham, E., Vincent, D., Kauffman, M., Mirza, M.R., Mau-Sorensen, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv310-iv310 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|